{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T01:44:33Z","timestamp":1794620673154,"version":"4.9.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","ejradiology.com","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.ejrad.2023.110798","type":"journal-article","created":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T15:26:03Z","timestamp":1679930763000},"page":"110798","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Prognostic value of metabolic tumor volume and lesion dissemination from baseline PET\/CT in patients with diffuse large B-cell lymphoma: Further risk stratification of the group with low-risk and high-risk NCCN-IPI"],"prefix":"10.1016","volume":"163","author":[{"given":"Hong","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangjie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuxin","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujiao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenguang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongguo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejrad.2023.110798_b0005","doi-asserted-by":"crossref","unstructured":"M. Sant, C. Allemani, C. Tereanu, R. De Angelis, R. Capocaccia, O. Visser, R. Marcos-Gragera, M. Maynadie, A. Simonetti, J.M. Lutz, F. Berrino, H.W. Group, Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project, Blood 116(19) (2010) 3724-34.","DOI":"10.1182\/blood-2010-05-282632"},{"issue":"11","key":"10.1016\/j.ejrad.2023.110798_b0010","first-page":"1013","article-title":"International Trial, CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group","volume":"12","author":"Pfreundschuh","year":"2011","journal-title":"LancetOncol"},{"issue":"4","key":"10.1016\/j.ejrad.2023.110798_b0015","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma","volume":"346","author":"Coiffier","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejrad.2023.110798_b0020","doi-asserted-by":"crossref","unstructured":"P. International Non-Hodgkin's Lymphoma Prognostic Factors, A predictive model for aggressive non-Hodgkin's lymphoma, N Engl J Med 329(14) (1993) 987-94.","DOI":"10.1056\/NEJM199309303291402"},{"issue":"5","key":"10.1016\/j.ejrad.2023.110798_b0025","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1182\/blood-2006-08-038257","article-title":"The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP","volume":"109","author":"Sehn","year":"2007","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.ejrad.2023.110798_b0030","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1182\/blood-2013-09-524108","article-title":"An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era","volume":"123","author":"Zhou","year":"2014","journal-title":"Blood"},{"issue":"Suppl 5","key":"10.1016\/j.ejrad.2023.110798_b0035","article-title":"Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"26","author":"Tilly","year":"2015","journal-title":"Ann. Oncol."},{"issue":"10","key":"10.1016\/j.ejrad.2023.110798_b0040","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1007\/s00259-021-05233-2","article-title":"Baseline PET\/CT imaging parameters for prediction of treatment outcome in Hodgkin and diffuse large B cell lymphoma: a systematic review","volume":"48","author":"Frood","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"8","key":"10.1016\/j.ejrad.2023.110798_b0045","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1007\/s00330-020-06815-8","article-title":"Baseline (18)F-FDG PET radiomic features as predictors of 2-year event-free survival in diffuse large B cell lymphomas treated with immunochemotherapy","volume":"30","author":"Aide","year":"2020","journal-title":"Eur. Radiol."},{"issue":"1","key":"10.1016\/j.ejrad.2023.110798_b0050","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2967\/jnumed.120.242412","article-title":"Deep-Learning (18)F-FDG Uptake Classification Enables Total Metabolic Tumor Volume Estimation in Diffuse Large B-Cell Lymphoma","volume":"62","author":"Capobianco","year":"2021","journal-title":"J. Nucl. Med."},{"issue":"5","key":"10.1016\/j.ejrad.2023.110798_b0055","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1007\/s00259-017-3907-x","article-title":"Combination of baseline FDG PET\/CT total metabolic tumour volume and gene expression profile have a robust predictive value in patients with diffuse large B-cell lymphoma","volume":"45","author":"Toledano","year":"2018","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"59","key":"10.1016\/j.ejrad.2023.110798_b0060","doi-asserted-by":"crossref","first-page":"99587","DOI":"10.18632\/oncotarget.20447","article-title":"Prognostic significance of total metabolic tumor volume on (18)F-fluorodeoxyglucose positron emission tomography\/ computed tomography in patients with diffuse large B-cell lymphoma receiving rituximab-containing chemotherapy","volume":"8","author":"Chang","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.ejrad.2023.110798_b0065","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2967\/jnumed.119.229450","article-title":"(18)F-FDG PET Dissemination Features in Diffuse Large B-Cell Lymphoma Are Predictive of Outcome","volume":"61","author":"Cottereau","year":"2020","journal-title":"J. Nucl. Med."},{"issue":"3","key":"10.1016\/j.ejrad.2023.110798_b0070","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.annonc.2020.11.019","article-title":"Risk stratification in diffuse large B-cell lymphoma using lesion dissemination and metabolic tumor burden calculated from baseline PET\/CT(\u2020)","volume":"32","author":"Cottereau","year":"2021","journal-title":"Ann. Oncol."},{"issue":"9","key":"10.1016\/j.ejrad.2023.110798_b0075","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.6004\/jnccn.2016.0117","article-title":"NCCN Guidelines Insights: Non-Hodgkin's Lymphomas, Version 3.2016","volume":"14","author":"Horwitz","year":"2016","journal-title":"J. Natl. Compr. Canc. Netw."},{"issue":"4","key":"10.1016\/j.ejrad.2023.110798_b0080","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s12185-011-0822-y","article-title":"High maximum standard uptake value (SUVmax) on PET scan is associated with shorter survival in patients with diffuse large B cell lymphoma","volume":"93","author":"Chihara","year":"2011","journal-title":"Int. J. Hematol."},{"issue":"7","key":"10.1016\/j.ejrad.2023.110798_b0085","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1007\/s00259-019-04309-4","article-title":"Prognostic value of metabolic tumour volume on baseline (18)F-FDG PET\/CT in addition to NCCN-IPI in patients with diffuse large B-cell lymphoma: further stratification of the group with a high-risk NCCN-IPI","volume":"46","author":"Shagera","year":"2019","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"7","key":"10.1016\/j.ejrad.2023.110798_b0090","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s00259-016-3315-7","article-title":"Combination of baseline metabolic tumour volume and early response on PET\/CT improves progression-free survival prediction in DLBCL","volume":"43","author":"Mikhaeel","year":"2016","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"21","key":"10.1016\/j.ejrad.2023.110798_b0095","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1200\/JCO.21.02063","article-title":"Proposed New Dynamic Prognostic Index for Diffuse Large B-Cell Lymphoma: International Metabolic Prognostic Index","volume":"40","author":"Mikhaeel","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.ejrad.2023.110798_b0100","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.clon.2010.11.001","article-title":"Adap.tive 18fluoro-2-deoxyglucose positron emission tomography\/computed tomography-based target volume delineation in radiotherapy planning of head and neck cancer","volume":"23","author":"Moule","year":"2011","journal-title":"Clin. Oncol. (R. Coll. Radiol.)"},{"issue":"8","key":"10.1016\/j.ejrad.2023.110798_b0105","first-page":"1342","article-title":"Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer","volume":"46","author":"Nestle","year":"2005","journal-title":"J. Nucl. Med."},{"issue":"51","key":"10.1016\/j.ejrad.2023.110798_b0110","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000009365","article-title":"Comparison of different automated lesion delineation methods for metabolic tumor volume of 18F-FDG PET\/CT in patients with stage I lung adenocarcinoma","volume":"96","author":"Wang","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.ejrad.2023.110798_b0115","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/MNM.0000000000000641","article-title":"Effect of different segmentation algorithms on metabolic tumor volume measured on 18F-FDG PET\/CT of cervical primary squamous cell carcinoma","volume":"38","author":"Xu","year":"2017","journal-title":"Nucl. Med. Commun."},{"issue":"2","key":"10.1016\/j.ejrad.2023.110798_b0120","doi-asserted-by":"crossref","DOI":"10.3390\/metabo11020072","article-title":"Reproducibility of Baseline Tumour Metabolic Volume Measurements in Diffuse Large B-Cell LymphomA: Is There a Superior Method?","volume":"11","author":"Eude","year":"2021","journal-title":"Metabolites"},{"issue":"7","key":"10.1016\/j.ejrad.2023.110798_b0125","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1007\/s00259-018-3953-z","article-title":"Defining the optimal method for measuring baseline metabolic tumour volume in diffuse large B cell lymphoma","volume":"45","author":"Ilyas","year":"2018","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"3","key":"10.1016\/j.ejrad.2023.110798_b0130","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2967\/jnumed.119.238923","article-title":"Automated Segmentation of Baseline Metabolic Total Tumor Burden in Diffuse Large B-Cell Lymphoma: Which Method Is Most Successful? A Study on Behalf of the PETRA Consortium","volume":"62","author":"Barrington","year":"2021","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ejrad.2023.110798_b0135","article-title":"Quantitative radiomics features in diffuse large B-cell lymphoma: does segmentation method matter?","author":"Eertink","year":"2021","journal-title":"J. Nucl. Med."},{"issue":"13","key":"10.1016\/j.ejrad.2023.110798_b0140","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1158\/1078-0432.CCR-16-0783","article-title":"Molecular Profile and FDG-PET Metabolic Volume at Staging in DLBCL-Response","volume":"22","author":"Cottereau","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.ejrad.2023.110798_b0145","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12149-020-01531-1","article-title":"Prognostic value of the baseline 18F-FDG PET\/CT metabolic tumour volume (MTV) and further stratification in low-intermediate (L-I) and high-intermediate (H-I) risk NCCNIPI subgroup by MTV in DLBCL MTV predict prognosis in DLBCL","volume":"35","author":"Zhao","year":"2021","journal-title":"Ann. Nucl. Med."}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X23001122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X23001122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T10:12:08Z","timestamp":1733220728000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X23001122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":29,"alternative-id":["S0720048X23001122"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2023.110798","relation":{},"ISSN":["0720-048X"],"issn-type":[{"value":"0720-048X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic value of metabolic tumor volume and lesion dissemination from baseline PET\/CT in patients with diffuse large B-cell lymphoma: Further risk stratification of the group with low-risk and high-risk NCCN-IPI","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejrad.2023.110798","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110798"}}